baber/WOPTO huggingface dataset:
Patent CN-100553691-C (CN)
Title: 羟基磷灰石嵌入氧化钛纳米管阵列复合涂层材料的制备方法
Inventor: XIUFENG XIAO
IPC: A61L27/32
Filed: 2007-02-26
Granted: 2009-10-28
Abstract: 本发明涉及一种羟基磷灰石嵌入氧化钛纳米管阵列的复合涂层材料的制备方法，其目的是提供一种活性涂层材料的制备方法。其特征在于：以钛或钛合金基体作为阳极，电解氧化制备出氧化钛纳米管阵列模板；配制出Ca(NO 3 ) 2 ·4H 2 O乙醇溶液和P 2 O 5 乙醇溶液，滴加混合后搅拌均匀即得羟基磷灰石溶胶；将羟基磷灰石以纳米线形式嵌入到氧化钛纳米管阵列中，经热处理后得到具有生物活性的复合涂层材料。本发明的特点在于羟基磷灰石深入钛或钛合金基体内部，避免了现有工艺羟基磷灰石涂层与基体存在宏观界面造成结合强度低的缺点，对基体的拉伸强度、断裂韧性不会产生本质影响，而表面的多孔性，可以减少植入体与骨弹性模量的差别，可用于各类骨的修复或替换。
Patent CN-100492785-C (CN)
Inventor: HONGFENG LIU
IPC: H01R39/64
Filed: 2007-04-29
Granted: 2009-05-27
Abstract: 一种径向绝缘叠片式导电滑环，属于电旋转连接器技术领域。导电环片(3)与绝缘片(4)相间排列安装在滑环轴(1)上，滑环轴(1)表面在安装导电环片的一段喷涂有高分子绝缘材料，以保证滑环轴(1)与导电环片(3)绝缘，安装在电刷架(9)上的电刷(7)与导电环片(3)紧密接触，电刷架(9)安装在轴套(2)上，滑环轴(1)和轴套(2)之间为滚动轴承支撑，滑环轴(1)相对轴套(2)转动时，通过导电环片引出线(8)和电刷引出线(6)实现相对旋转零部件之间多路电信号的传输。本发明有效简化了生产工艺，减小了滑环径向尺寸，增加了轴的刚度。
Patent CN-100563717-C (CN)
Title: Lyrm1基因在制备促进脂肪细胞增殖药物中的应用
Inventor: XIRONG GUO
IPC: A61K38/17
Filed: 2008-08-26
Granted: 2009-12-02
Abstract: 本发明属于基因工程领域，公开了LYRM1基因在制备促进脂肪细胞增殖药物中的应用。本发明的技术方案为LYRM1基因、LYRM1基因编码的蛋白及其融合蛋白在制备促进脂肪细胞增殖药物中的应用。本发明为制备促进脂肪细胞增殖药物提供了可用的基因序列，为研究肥胖的发生发展提供了新的研究手段。
Patent SE-501209-E (SE)
Inventor: JACQUET BILLY
IPC: B26F1/32
Filed: 1989-09-04
Abstract: The frame (1) and the operating component (2) consist of two extrusion pressed profiles with parts (3,7A) which engage each other for pivotable location of the operating component in relation to the frame. - The operating component has a track (6) for pivotable location but axial locking of the punches (4) in relation to it. The engaging parts and the track and the punches are so formed that for storage purposes the operating component can be folded together, as well as the punches.
Patent PT-1192469-E (PT)
Title: Assay
Inventor: HAAHEIM LARS REINHARDT
IPC: G01N33/569
Filed: 2000-06-14
Abstract: The present invention provides a method of determining the presence or amount of newly synthesised antibody in a sample in response to an immunogen by detecting the released antibodies or parts thereof in a sample containing lymphocytes which have been disrupted whereby to release the synthesised antibodies or parts thereof associated with said lymphocytes whereby to determine the presence or amount of newly synthesised antibody in said sample, methods of diagnosis using said method and kits for performing the method. The method may also be modified to allow detection of non-specific infection indicators.
Patent PT-1240212-E (PT)
Inventor: LABARRE DENIS
IPC: C08F8/32
Filed: 2000-10-03
Abstract: The invention relates to cross-linked copolymers based on non cross-linked polycarboxylic copolymers, said non cross-linked copolymers containing at least one polysaccharide. The invention also relates to a process for the preparation of these copolymers and their use in particular as a support in pharmaceutical compositions.
Patent PT-1307455-E (PT)
Inventor: ILA SIRCAR
IPC: C07D471/04
Filed: 2000-10-19
Abstract: The present invention relates to a compound of formula: (I), or a pharmaceutically acceptable salt thereof.
Patent PT-1120117-E (PT)
Title: Method of increasing the production of eggs and strengthening eggshells in poultry
Inventor: BARDON THIERRY
IPC: A23K1/24
Filed: 2001-01-11
Abstract: The present invention relates to a process for increasing the egg production and strengthening the eggshells of poultry, which comprises the administration to the animal of at least one bisphosphonic compound chosen from a bisphosphonic acid, a physiologically acceptable salt thereof, hydrates thereof and mixtures thereof.
Patent PT-1252322-E (PT)
Inventor: STUART COFFIN ROBERT
IPC: A61K39/00
Filed: 2001-01-22
Abstract: The present invention relates to the use of a modified, oncolytic, herpes simplex virus (HSV) strain in the manufacture of a medicament for the oncolytic treatment of cancer, which HSV strain: 
(a) has a greater ability than HSV1 17+, HSV1 F and HSV1 KOS strains with equivalent modifications to replicate in or kill tumour cells; and 
(b) is obtainable by isolating an HSV strain from a host and modifying the isolated HSV strain to provide for selective replication in tumour cells.
Patent PT-1362213-E (PT)
Inventor: HANS RUEEGG
IPC: F27D25/00
Filed: 2002-03-25
Abstract: An on-line method and a device for cleaning of contamination such as caking or slag deposits from surfaces in vessels and combustion installations by means of blasting technology. An explosive gas mixture is made to detonate in the proximity of the deposits and thereby clean the deposits from the surfaces.
Patent PT-1400586-E (PT)
Title: Substrates containing a trichoderma asperellum strain for biological control of fusarium and rhizoctonia
Inventor: GAY MARIA ISABEL TRILLAS
IPC: A01N63/38
Filed: 2002-06-25
Abstract: The strain of Trichoderma asperellum T34(2) CECT No. 20417 is useful for preparing substrates for biological control of vascular fusariose and death of plants caused by Rhizoctonia solani. The substrates can be peats, composts (hardwood compost, pine bark compost, cork compost, sludge compost from sewage treatment plants, garden residues, etc.) or formulations based on CPV-type compost (compost + peat + vermiculite). The fact that said substrates suppress both Fusarium oxysporum f. sp. lycopersici and Rhizoctonia solani provides an advantage in comparison with other substrates known in prior art. Another advantage is that the use of methyl bromide, a highly harmful product for the environment, in the control of vascular fusariose is avoided.
Patent PT-1458774-E (PT)
Title: Food coating substance containing a softener-free, aqueous copolymer poly(vinyl ester) dispersion, production and use thereof
IPC: A23P20/00
Filed: 2002-12-23
Abstract: A novel food coating substance comprising a plasticizer-free aqueous copolymer poly(vinyl ester) dispersion of emulsion polymer, emulsifier, protective colloid and optionally other stabilizers is outstandingly suitable for the surface treatment or surface coating of hard cheese or semi-hard cheese, but also of meat products, fruits, nuts or seed material.
Patent PT-1393744-E (PT)
Title: Acellular pertussis vaccines and methods of preparation thereof
Inventor: THIPPHAWONG JOHN
IPC: C07K14/235
Filed: 1996-05-02
Abstract: Vaccine for protecting humans against Bordetella pertussis infection comprises pertussis toxoid (I), filamentous haemagglutinin (II), pertactin (III) and agglutinogens (IV) of B. pertussis in relative amts. able to confer protection to >= 70% of an at-risk population. A single dose is 5-30 mu g (I) and (II), 3-15 mu g (III) and 1-10 mu g (IV), all expressed as nitrogen contents, esp. 10 mu g (I) and 5 mu g (II) or 20 mu g each of these, plus 5 mu g (III) and 3 mu g (IV). Vaccines are administered by subcutaneous or intramuscular injection. (IV) comprises fimbrial agglutinogens (Agg) 2 and 3 (pref. at ratio 1.5-2:1) but is free of Agg 1. These may also include diphtheria toxoid, pref. at 15 Lfs, and tetanus toxoid, pref. at 5 Lf, opt. also other non-Bordetella antigens. They can also include an adjuvant, specifically alum.
Patent PT-1527042-E (PT)
Title: Method for producing aminoalkoxy benzylamines and aminoalkoxy benzonitriles as intermediates
Inventor: MELDER JOHANN-PETER
IPC: C07B61/00
Filed: 2003-07-18
Abstract: The invention relates to a process for preparing 4-[aminoalkoxy]benzylamines of the general formula (I) by catalytically hydrogenating 4-[aminoalkoxy]benzonitriles of the general formula (II) where, in the compounds of the general formulae I and II, R<SUP>1 </SUP>is C<SUB>1</SUB>-C<SUB>8</SUB>-alkylene, R<SUP>2 </SUP>and R<SUP>3 </SUP>are each independently C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl or are joined to give a ring which may additionally contain a heteroatom, which comprises carrying out the hydrogenation at elevated pressure and elevated temperatures. The invention further relates to a process for preparing the intermediate (II).
Patent PT-1593393-E (PT)
Title: Anti-tnf antibodies and methotrexate in the concomitant treatment of autoimmune diseases
Inventor: FELDMAN MARC
IPC: C07K16/24
Filed: 1997-08-01
Abstract: Use of a tumour necrosis factor (TNF) antagonist for the preparation of a medicament for treatment of a TNF-mediated disease, wherein the TNF antagonist is to be administered as adjunctive therapy to methotrexate.
Patent PT-1695985-E (PT)
Title: Methods for forming humanised antibodies by random mutagenesis
Inventor: WELLS JAMES A
IPC: C12P21/08
Filed: 1998-04-03
Abstract: Humanized and variant anti-VEGF antibodies and various uses therefore are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells  in vitro,  and inhibit tumor growth  in vivo.
Patent PT-1833798-E (PT)
Title: A process for the preparation of (s)-(+)-10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide
Inventor: BREVIGLIERI GABRIELE
IPC: C07D223/28
Filed: 2005-11-15
Abstract: (S)-(+)-10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxyamide is prepared starting from racemic 5-cyano-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine by phthaloylation, separation of the diastereomeric salts of the phthaloyl derivative with (S)-phenylethylamine, hydrolysis of the (S, S) salt to (S)-(+)-5-cyano-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine and hydrolysis of the nitrile group of the latter to amido group, by treatment with peroxy compounds in alkali medium.
Patent PT-1887888-E (PT)
Title: Use of polydextrose for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
Inventor: GIBSON GLENN R
IPC: A23L33/00
Filed: 2006-03-23
Abstract: The present invention is directed to a composition for simulating the functional attributes of human milk oligosaccharides comprising polydextrose and galactooligosacharide, wherein the total amount of the combination of polydextrose and galactooligosaccharide in the composition is between 1.0 g/L and 10.0 g/L.
Patent PT-1927525-E (PT)
Title: Mobile part supply unit for supplying production lines
Inventor: JEANNENEZ CHRISTOPHE
IPC: B62B5/00
Filed: 2007-11-29
Abstract: The trolley (1) has a receptacle (2) for receiving and supporting parts to be transported and provided with non-driven guiding wheels (5) ensuring free displacement on the ground due to a transversal effort applied on the receptacle. A drive wheel (11) is associated with an electromagnetic clutch and is driven by an axle (20) of a gear motor (21) activated by a control knob carried by the receptacle. The axle co-operates with notches of a toothed belt (19) gripped with a pinion placed on an output axle of the clutch with the drive wheel, where each wheel has an external tire made of rubber.
Patent PT-1979226-E (PT)
Title: Flotation device
Inventor: JEFFREY PETER
IPC: B63B22/10
Filed: 2007-02-01
Abstract: A device which will act efficiently as a float for any article (e.g. keys, mobile telephone, wallet) attached thereto when dropped into water comprises an inflatable bag (14') of substantially waterproof and air impervious material, a container (12) of compressed gas, and trigger means (16,30,32) associated with the container (12) and operable upon immersion of the device in water to open the container (12) and allow gas from the container (14') to inflate the bag (14). The trigger means comprises a valve (16) mounted on the container (12) and connecting the container to the inflatable bag (14'), retainer means (64) operative to hold the valve (16) in a closed condition, and water reactive means (66) which, upon contact with water, serves to release the retainer means (64) and allow the valve to open, e.g. under spring bias. The water reactive means may comprise a band of material (66), at least part of which is water reactive. The bag (14'), the container (12) and the trigger means are housed in a casing (10) and means (37) are provided, preferably integrally on the container (12), for attachment of the device to another article.  An illumination device (50) is mounted inside the inflatable bag (14'). This preferably includes a light emitting diode (LED) (52) powered by at least one battery (54), the latter being automatically connected to the LED upon inflation of the bag by withdrawal of an intervening strip of insulating material.
Patent PT-1990270-E (PT)
Title: Submarine
Inventor: KOELSCH ANDREAS
IPC: B63B17/06
Filed: 2008-03-18
Abstract: A sluice/sewer (2) has inner (10) and outer (12) sealing bodies. The outer sealing body can be moved away partly for opening a pressure hull (4) and placed outwards to be flexible against shocks in its closing position in a direction normal to an opening cross-section of the sluice/sewer waiting to be opened.
Patent PT-2100808-E (PT)
Title: Device for lowering the drive output requirements of a ship
Inventor: MEWIS FRIEDRICH
IPC: B63H5/16
Filed: 2008-06-17
Abstract: The device (10) has a front nozzle (20) including fins or air foils (30, 30d) arranged within the front nozzle, where the device is firmly attached to a ship body (100). Inner diameter of the front nozzle is smaller than 90 percent of an air-screw diameter. The front nozzle is arranged rotation-symmetrically with an axis (21) lying above an air-screw axis (PA). The fins and the air foils are arranged asymmetrically in an inner space (20a) of the front nozzle and radially to the air screw axis.
Patent PT-2133254-E (PT)
Title: Method for a rail vehicle to actuate safety reactions
Inventor: BURG WILHELM
IPC: B61L15/00
Filed: 2009-05-12
Abstract: The method involves detecting a condition in which a safety reaction is performed using a safety reaction requesting device. The safety reaction is requested by the device via a data bus. The performed safety reaction is acknowledged at the device. A safety loop for activating the desired safety reaction is engaged when the safety reaction is not performed. A low-wear full brake application is continuously requested during a brake requirement. The brake application is acknowledged via a pressure measurement value for a main brake pipe (HL) of a rail vehicle.
Patent PT-2277551-E (PT)
Title: Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto
Inventor: DAVIS MARK E
IPC: C08G63/48
Filed: 2003-09-04
Abstract: The present invention relates to novel compositions of therapeutic cyclodextrin containing polymeric compounds designed as a carrier for small molecule therapeutics delivery and pharmaceutical compositions thereof. These cyclodextrin-containing polymers improve drug stability and solubility, and reduce toxicity of the small molecule therapeutic when used in vivo. Furthermore, by selecting from a variety of linker groups and targeting ligands the polymers present methods for controlled delivery of the therapeutic agents. The invention also relates to methods of treating subjects with the therapeutic compositions described herein. The invention further relates to methods for conducting pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the polymeric compounds described herein.
Patent PT-672067-E (PT)
Inventor: STJERNSCHANTZ JOHAN
IPC: A61K39/395
Filed: 1993-10-01
Abstract: PCT No. PCT/SE93/00789 Sec. 371 Date Apr. 13, 1995 Sec. 102(e) Date Apr. 13, 1995 PCT Filed Oct. 1, 1993 PCT Pub. No. WO94/07920 PCT Pub. Date Apr. 14, 1994Molecular cloning and expression of a prostaglandin F2 alpha  receptor which is linked to the signal transduction pathways via guanine nucleotide binding regulatory (G) proteins and measured by, for example, cAMP, IP3 or intracellular calcium. By constructing cell lines that express a prostaglandin F2 alpha , receptor, the affinities and efficacies of agonist and antagonist drugs with the receptor can be assessed. A recombinant DNA construct includes a vector and a DNA fragment encoding a prostaglandin F2 alpha  receptor. A host cell is transformed with a recombinant DNA construct, so that the DNA fragment is expressed and a prostaglandin F2 alpha , receptor is produced. Suitable host systems include eukaryotic and prokaryotic cells, especially mamalian cells such as rat or human. Additionally, for diagnostic purposes, antibodies to a prostaglandin F2 alpha  receptor can be prepared by producing all or a portion of the receptor protein and injecting these into various types of mammals. Using the resulting antibodies, expression of an F2 alpha  receptor cDNA, i.e. receptor protein in tissue and cells can be measured.
Patent PT-691113-E (PT)
Inventor: COLLYER GRAHAM
IPC: A61F13/02
Filed: 1995-05-31
Abstract: A wound dressing for moist wounds is formed from a body layer (1) with a wound-contacting layer (3) attached to an inner surface and a barrier backing layer (2) attached to an outer surface. The body layer (1) is a resiliently compressible moisture-absorbent polyurethane foam film. The wound-contacting layer (3) is a preferably hydrophilic moisture permeable foam film. The barrier backing layer (2) is a liquid and bacteria proof gas-permeable foam
Patent PT-805659-E (PT)
Inventor: OUSDAL SVEIN
IPC: A61F5/042
Filed: 1996-01-11
Abstract: A device for exerting force between two portions of the human anatomy, such as a back or neck. The device includes an upper brace for attachment to an upper portion of the human anatomy and a lower brace for attachment to a lower portion of the human anatomy. The first and the second fluid containing cylinder, each cylinder having a lower portion and a telescopically extendable upper portion, have attachment means thereon and extend generally in a longitudinal direction of a patient. The first cylinder upper portion is attached to the upper brace, the first cylinder lower portion is attached to the lower brace. The second cylinder upper portion is attached to the upper brace and the second cylinder lower portion is attached to the lower brace. The first and second cylinders are positioned on opposite sides of the human anatomy with the fluid within the cylinders being compressive and under compression providing a constant force urging the upper brace away from the lower brace. The upper brace has an articulation mechanism for providing mobility to the patient.
Patent PT-857369-E (PT)
Inventor: GEHRE HANS-JOACHIM
IPC: H02J9/06
Filed: 1996-10-23
Abstract: PCT No. PCT/DE96/02011 Sec. 371 Date Jun. 18, 1998 Sec. 102(e) Date Jun. 18, 1998 PCT Filed Oct. 23, 1996 PCT Pub. No. WO97/15976 PCT Pub. Date May 1, 1997A back-up device includes at least one back-up battery, in particular a rechargeable battery which can be charged via the power supply, and a control unit. The control unit connects the back-up battery when the actual value of the DC voltage is less than a predefined minimum value, generates a predefined back-up time period and disconnects the back-up battery again, cyclically, after this time period has elapsed. The device has the advantage that the return of the output DC voltage of the power supply can be identified effectively without major complexity. The loads continue to be supplied both in the event of a failure of the supplying input voltage and in the event of a failure of the power supply, since the output DC voltage, which is essential for the loads, of the power supply is monitored. The device can be connected additively downstream of a power supply, without any intervention in its design being necessary. The device has the further advantage that it automatically connects the battery as a back-up, even in the event of dips in the output DC voltage caused by short-circuits, as soon as the load voltage falls below the minimum value. Thus, the device allows a virtually continuous transfer and back-up of the output DC voltage in a multiplicity of fault situations.
Patent PT-891734-E (PT)
Inventor: MASEK PETR
IPC: A47J31/36
Filed: 1997-07-14
Abstract: The coffee is in a capsule (11) which has a cup (9) and a projecting edge (12). This is held in a cylindrical cage (1) whose inner shape (5) corresponds to the shape of the capsule. It has a water injector at the top and an annular stop (8) at the bottom. The capsule holder (13) has a cylindrical hole (14) and an extraction plate (15) in its base. The annular stop of the cage engages with the periphery of the plate (21). Feet (19) near the plate are shaped in the arc of a circle and retain the edge of the capsule.
Patent PT-908924-E (PT)
Inventor: BRANDE PIERRE VANDEN
IPC: C23C14/34
Filed: 1997-10-08
Abstract: A device for forming a coating on a substrate (8) by condensation of an element, notably a metal, incorporates a conducting wall (9, 9a, 9b) delimiting at least laterally the space (2') between the target (7) and the substrate (8) with provision for negative or positive polarization of this wall (9, 9a, 9b) with respect to the substrate (8). The device comprises:- a) an enclosure (2) in which is a target (7) presenting at least a surface layer of the material to be condensed onto the substrate; b) some means (1) for evaporating this material; and/or c) some means for producing the cathodic pulverization of this material from the target (7) to the substrate (8).
Patent PT-951853-E (PT)
Inventor: JOERGENSEN CARSTEN
IPC: A47J31/56
Filed: 1998-11-25
Abstract: A device for preparing beverages of the type having a closed compartment (c2), an open compartment (c1), an ascension pipe (23) connecting the compartments, and a filtering device (f1) between the ascension pipe (23) and the open compartment (c1), has some disadvantages in that an external heating source is needed, thereby increasing the risk of fire and burning the operating persons. Further, the infusion time is either fixed, being decided by the distance between the lower orifice of the ascending pipe and the bottom of the closed compartment or left to the user to estimate. The inventor has consequently suggested, that the bottom of the closed compartment (c2) at least has two levels (H1, H4), one level of deminished elevation (H4) in a relatively small area around the lower orifice of the ascension pipe (23), the level (H3) of which is at least below the other elevated level (H1) of a relatively large area, said large area being equipped with electrical heating means (he1, he2) controlled by switching means and at least one temperature sensitive means ( theta ) for controlling the switching means, said large area of the bottom being surrounded by a rim (25) for holding a residual of liquid. <IMAGE>
Patent PT-943865-E (PT)
Inventor: TONELLI CLAUDIO
IPC: F23Q7/00
Filed: 1998-03-16
Abstract: A glow plug for diesel engines, comprising a fixing bush (62) and a capsule (20) provided with a tubular housing (22) from which projects a sheath element (24) containing a heating resistor (26). The fixing bush (62) and the capsule (20) are two separate components, in order to improve concentricity and coaxiality tolerances for plugs with long bodies intended to be fitted into deep wells. <IMAGE>
Patent PT-987368-E (PT)
Inventor: KARL-HEINZ SCHWIEDE
IPC: E01B5/18
Filed: 1999-09-16
Abstract: To mount the inner check rail (9) to the sleeper (1), in a railway permanent way, a support pedestal (5) is fitted with check rail plates (3). With a support pedestal (5) under the check rail laying surface (17), passage openings (18,19) hold hook bolts (10) which grip against the inner check rail (9) with a clamping pad (14). The passage opening (18) acts as a guide (19,20) for key surfaces (12,12b) of the hook bolt (10) at least at the side towards the running rail (2). The hook bolt (10) is supported in the guide (19) with a flat upper side (12a) and an offset lower key surface (12b).
Patent PT-1045877-E (PT)
Inventor: FISCHER HARTMUT RUDOLF
IPC: C08F2/44
Filed: 1999-01-08
Abstract: The invention relates to a nanocomposite material based on a polymeric matrix and a layered double hydroxide, wherein the polymeric matrix is present in an amount of at least 50% by weight, based on the nanocomposite material, and wherein the layered double hydroxide contains an amount of anions of at least 20%, based on the total number of anions of the layered double hydroxide, which anions are compatible and/or reactive with the polymeric matrix, and wherein at least 5% of the above amount of anions contain a second charge-carrying group. The invention further relates to a method for preparing such a nanocomposite material and to a shaped article from such a nanocomposite material.